ISRCTN14618196已完成未知
Assessment of increasing intravenous adenosine dose in fractional flow reserve: a non-randomized trial
und University0 个研究点目标入组 75 人开始时间: 2016年12月15日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
2017 results in https://pubmed.ncbi.nlm.nih.gov/28196527/ (added 27/11/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age =18 years
- •2. Borderline-significant coronary stenosis (indication for FFR according to ESC Guidelines)
- •3. Signed informed consent prior to enrollment
排除标准
- •1. Allergy to adenosine or contrast media
- •2. Baseline mean arterial pressure <60 mmHg
- •3. Baseline heart rate <50 bpm
- •4. Pharmacologically treated asthma
- •5. Chronic obstructive pulmonary disease equivalent to GOLD classification III and IV
- •6. Confusion or inability to comprehend the study information
研究者
相似试验
Unknown
不适用
Hyperemic Efficacy of IV Adenosine in HFrEFHeart Failure With Reduced Ejection FractionCoronary Artery DiseaseNCT03235700Sejong General Hospital125
已完成
不适用
Adenosine Administration during and after Primary percutaneous coronary intervention in acute myocardial infarction – a Randomized Controlled Trial (ADAPT).1. Percutaneous coronary intervention<br />2. Myocardial infarction<br /> 3. Reperfusion therapy.NL-OMON22898niversity Medical Center Groningen, <br>Thoraxcenter, Dept Cardiology.450
已完成
不适用
To evaluate whether intravenous Adenosine would replace the need for inhaled nitric oxide (iNO) in the management of Persistent Pulmonary Hypertension of the Newborn (PPHN)eonatal Diseases: Persistant pulmonary hypertensionNeonatal DiseasesOther pulmonary heart diseasesISRCTN51768118Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)9
已完成
不适用
Rapid Measurement of Adenosine in Syncope PatientsSyncopeNCT05782712Istituto Auxologico Italiano235
尚未招募
不适用
High dose adenosine in acute myocardial infarction studyPatients with acute myocardial infarction treated by primary PCINL-OMON23567none80